908 Devices Inc. (NASDAQ: MASS) Stock Competitors & Peer Comparison
See MASS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MASS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MASS | $10.02 | +0.10% | 411.1M | -16.70 | -$0.60 | N/A |
| ALC | $73.58 | -2.35% | 35.9B | 23.15 | $3.18 | +0.49% |
| STE | $236.60 | -0.68% | 23.1B | 22.70 | $10.42 | +1.07% |
| BRKRP | $437.99 | +2.57% | 8.8B | 239.01 | $1.84 | +0.35% |
| DRTSW | $3.57 | -8.23% | 1.4B | -5.53 | -$0.65 | N/A |
| SI | $19.34 | -1.48% | 401.9M | -10.12 | -$1.91 | N/A |
| MOBI | $11.52 | -8.43% | 383M | -0.61 | -$18.78 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| NYXH | $1.58 | -0.63% | 158.1M | -0.63 | -$2.52 | N/A |
| APYX | $2.99 | -0.99% | 125.9M | -13.59 | -$0.22 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
MASS vs ALC Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, ALC has a market cap of 35.9B. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while ALC trades at $73.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas ALC's P/E ratio is 23.15. In terms of profitability, MASS's ROE is -0.25%, compared to ALC's ROE of +0.04%. Regarding short-term risk, MASS is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for MASS.Check ALC's competition here
STERIS plc (NYSE: STE)
MASS vs STE Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, STE has a market cap of 23.1B. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while STE trades at $236.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas STE's P/E ratio is 22.70. In terms of profitability, MASS's ROE is -0.25%, compared to STE's ROE of +0.11%. Regarding short-term risk, MASS is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for MASS.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
MASS vs BRKRP Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while BRKRP trades at $437.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas BRKRP's P/E ratio is 239.01. In terms of profitability, MASS's ROE is -0.25%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, MASS is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for MASS.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
MASS vs DRTSW Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, DRTSW has a market cap of 1.4B. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while DRTSW trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas DRTSW's P/E ratio is -5.53. In terms of profitability, MASS's ROE is -0.25%, compared to DRTSW's ROE of -0.73%. Regarding short-term risk, MASS is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for MASS.Check DRTSW's competition here
Shoulder Innovations, Inc. (NYSE: SI)
MASS vs SI Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, SI has a market cap of 401.9M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while SI trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas SI's P/E ratio is -10.12. In terms of profitability, MASS's ROE is -0.25%, compared to SI's ROE of -0.24%. Regarding short-term risk, MASS is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for MASS.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
MASS vs MOBI Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, MOBI has a market cap of 383M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while MOBI trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas MOBI's P/E ratio is -0.61. In terms of profitability, MASS's ROE is -0.25%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, MASS is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for MASS.Check MOBI's competition here
Edap Tms S.a. (NASDAQ: EDAP)
MASS vs EDAP Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MASS's ROE is -0.25%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, MASS is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for MASS.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
MASS vs NYXH Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, NYXH has a market cap of 158.1M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while NYXH trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas NYXH's P/E ratio is -0.63. In terms of profitability, MASS's ROE is -0.25%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MASS is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for MASS.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
MASS vs APYX Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, APYX has a market cap of 125.9M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while APYX trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas APYX's P/E ratio is -13.59. In terms of profitability, MASS's ROE is -0.25%, compared to APYX's ROE of -0.79%. Regarding short-term risk, MASS is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for MASS.Check APYX's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
MASS vs MDAI Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, MDAI has a market cap of 50M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while MDAI trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas MDAI's P/E ratio is -3.49. In terms of profitability, MASS's ROE is -0.25%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, MASS is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for MASS.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
MASS vs WOK Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, WOK has a market cap of 5M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while WOK trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas WOK's P/E ratio is N/A. In terms of profitability, MASS's ROE is -0.25%, compared to WOK's ROE of -0.07%. Regarding short-term risk, MASS is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for MASS.Check WOK's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
MASS vs FEED Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, FEED has a market cap of 3.8M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while FEED trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas FEED's P/E ratio is -0.01. In terms of profitability, MASS's ROE is -0.25%, compared to FEED's ROE of -0.44%. Regarding short-term risk, MASS is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for MASS.Check FEED's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
MASS vs QTEXW Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MASS's ROE is -0.25%, compared to QTEXW's ROE of N/A. Regarding short-term risk, MASS is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MASS.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
MASS vs ITOC Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, ITOC has a market cap of 2.9M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while ITOC trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas ITOC's P/E ratio is -0.98. In terms of profitability, MASS's ROE is -0.25%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MASS is more volatile compared to ITOC. This indicates higher risk in terms of short-term price fluctuations for MASS.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
MASS vs BIAFW Comparison August 2026
908 Devices Inc. (NASDAQ: MASS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MASS stands at 411.1M. In comparison, BIAFW has a market cap of 2.5M. Regarding current trading prices, MASS is priced at $10.02 on the NASDAQ, while BIAFW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MASS currently has a P/E ratio of -16.70, whereas BIAFW's P/E ratio is 0.27. In terms of profitability, MASS's ROE is -0.25%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, MASS is more volatile compared to BIAFW. This indicates higher risk in terms of short-term price fluctuations for MASS.Check BIAFW's competition here